Veterinary Regenerative Medicine Market 2030: Innovations in Pet Care
Veterinary Regenerative Medicine Market Overview The global veterinary regenerative medicine market was valued at USD 257.54 million in 2022 and is projected to grow to USD 640.16 million by 2030, registering a compound annual growth rate (CAGR) of 12.54% from 2023 to 2030. This growth is driven by rising expenditures on pet care, increasing research and development efforts in regenerative medicine, the growing prevalence of both acute and chronic illnesses in companion animals, and initiatives undertaken by key market players. For example, in July 2020, Boehringer Ingelheim enhanced its stem cell capabilities in veterinary medicine by acquiring Global Stem cell Technology (GST), a Belgian veterinary biotech firm. However, the COVID-19 pandemic had a significant effect on the market, causing restricted access to veterinary services, increased pet adoption, disruptions in the supply chain, operational limitations, and a temporary decline in demand. These challenges were compounded by...